Ingelman-Sundberg M - Search Results

1

Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.

Rodríguez-Antona C, Jande M, Rane A, Ingelman-Sundberg M. Rodríguez-Antona C, et al. Clin Pharmacol Ther. 2005 Apr;77(4):259-70. doi: 10.1016/j.clpt.2004.11.003. Clin Pharmacol Ther. 2005. PMID: 15903124

2

Properties of hydroxylase systems in the human fetal liver active on free and sulfoconjugated steroids.

Ingelman-Sundberg M, Rane A, Gustafasson JA. Ingelman-Sundberg M, et al. Biochemistry. 1975 Jan 28;14(2):429-37. doi: 10.1021/bi00673a033. Biochemistry. 1975. PMID: 1120111

3

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population.

Dahl ML, Johansson I, Palmertz MP, Ingelman-Sundberg M, Sjöqvist F. Dahl ML, et al. Clin Pharmacol Ther. 1992 Jan;51(1):12-7. doi: 10.1038/clpt.1992.2. Clin Pharmacol Ther. 1992. PMID: 1346258

4

Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine.

Johansson I, Yue QY, Dahl ML, Heim M, Säwe J, Bertilsson L, Meyer UA, Sjöqvist F, Ingelman-Sundberg M. Johansson I, et al. Eur J Clin Pharmacol. 1991;40(6):553-6. doi: 10.1007/BF00279968. Eur J Clin Pharmacol. 1991. PMID: 1679392

5

Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.

Dahl ML, Johansson I, Bertilsson L, Ingelman-Sundberg M, Sjöqvist F. Dahl ML, et al. J Pharmacol Exp Ther. 1995 Jul;274(1):516-20. J Pharmacol Exp Ther. 1995. PMID: 7616439

6

Induction mechanisms of cytochrome P450 2E1 in liver: interplay between ethanol treatment and starvation.

Hu Y, Ingelman-Sundberg M, Lindros KO. Hu Y, et al. Biochem Pharmacol. 1995 Jul 17;50(2):155-61. doi: 10.1016/0006-2952(95)00128-m. Biochem Pharmacol. 1995. PMID: 7632158

7

Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe.

Masimirembwa C, Bertilsson L, Johansson I, Hasler JA, Ingelman-Sundberg M. Masimirembwa C, et al. Clin Pharmacol Ther. 1995 Jun;57(6):656-61. doi: 10.1016/0009-9236(95)90228-7. Clin Pharmacol Ther. 1995. PMID: 7781265

8

Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.

Johansson I, Oscarson M, Yue QY, Bertilsson L, Sjöqvist F, Ingelman-Sundberg M. Johansson I, et al. Mol Pharmacol. 1994 Sep;46(3):452-9. Mol Pharmacol. 1994. PMID: 7935325

9

Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver.

Hu Y, Mishin V, Johansson I, von Bahr C, Cross A, Ronis MJ, Badger TM, Ingelman-Sundberg M. Hu Y, et al. J Pharmacol Exp Ther. 1994 Jun;269(3):1286-91. J Pharmacol Exp Ther. 1994. PMID: 8014872

10

Acetone-dependent regulation of cytochromes P4502E1 and P4502B1 in rat nasal mucosa.

Longo V, Ingelman-Sundberg M. Longo V, et al. Biochem Pharmacol. 1993 Dec 3;46(11):1945-51. doi: 10.1016/0006-2952(93)90635-a. Biochem Pharmacol. 1993. PMID: 8267643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters